Back to Search Start Over

A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid Cancer

Authors :
Anna M. Sawka
Sangeet Ghai
George Tomlinson
Nancy N. Baxter
Martin Corsten
Syed Ali Imran
Eric Bissada
Rebecca Lebouef
Nathalie Audet
Maryse Brassard
Han Zhang
Michael Gupta
Anthony C. Nichols
Deric Morrison
Stephanie Johnson-Obeski
Eitan Prisman
Don Anderson
Shamir P. Chandarana
Sana Ghaznavi
Jennifer Jones
Amiram Gafni
John J. Matelski
Wei Xu
David P. Goldstein
the Canadian Thyroid Cancer Active Surveillance Study Group
Lorne Rotstein
Dale Brown
John de Almeida
Patrick Gullane
Ralph Gilbert
Douglas Chepeha
Jonathan Irish
Jesse Pasterna
Shereen Ezzat
James P. Brierley
Richard W. Tsang
Eric Monteiro
Afshan Zahedi
Jacqueline Jame
Karen Gomez Hernandez
Antoine Eskander
Danny Enepekides
Kevin Higgins
Ilana J. Halperin
Karen Devon
Everton Gooden
Manish Shah
Mark Korman
Janet Chung
Kareem Nazarali
Eric Arruda
Artur Gevorgyan
Michael Chang
Sumeet Anand
Vinay Fernandes
Denny Lin
Avik Banerjee
Vinita Bindlish
Vinod Bharadwaj
Maky Hafidh
Raewyn Seaburg
Laura Whiteacre
Source :
Frontiers in Endocrinology, Vol 12 (2021)
Publication Year :
2021
Publisher :
Frontiers Media S.A., 2021.

Abstract

BackgroundThe traditional management of papillary thyroid cancer (PTC) is thyroidectomy (total or partial removal of the thyroid). Active surveillance (AS) may be considered as an alternative option for small, low risk PTC. AS involves close follow-up (including regularly scheduled clinical and radiological assessments), with the intention of intervening with surgery for disease progression or patient preference.MethodsThis is a protocol for a prospective, observational, long-term follow-up multi-centre Canadian cohort study. Consenting eligible adults with small, low risk PTC (< 2cm in maximal diameter, confined to the thyroid, and not immediately adjacent to critical structures in the neck) are offered the choice of AS or surgery for management of PTC. Patient participants are free to choose either option (AS or surgery) and the disease management course is thus not assigned by the investigators. Surgery is provided as usual care by a surgeon in an institution of the patient’s choice. Our primary objective is to determine the rate of ‘failure’ of disease management in respective AS and surgical arms as defined by: i) AS arm – surgery for progression of PTC, and ii) surgical arm - surgery or other treatment for disease persistence or progression after completing initial treatment. Secondary outcomes include long-term thyroid oncologic and treatment outcomes, as well as patient-reported outcomes.DiscussionThe results from this study will provide long-term clinical and patient reported outcome evidence regarding active surveillance or immediate surgery for management of small, low risk PTC. This will inform future clinical trials in disease management of small, low risk papillary thyroid cancer.Registration detailsThis prospective observational cohort study is registered on clinicaltrials.gov (NCT04624477), but it should not be considered a clinical trial as there is no assigned intervention and patients are free to choose either AS or surgery.

Details

Language :
English
ISSN :
16642392
Volume :
12
Database :
Directory of Open Access Journals
Journal :
Frontiers in Endocrinology
Publication Type :
Academic Journal
Accession number :
edsdoj.3cd6772974e4fb88d49087c38c0732c
Document Type :
article
Full Text :
https://doi.org/10.3389/fendo.2021.686996